Literature DB >> 8421497

A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism.

E M Rinchik1, S J Bultman, B Horsthemke, S T Lee, K M Strunk, R A Spritz, K M Avidano, M T Jong, R D Nicholls.   

Abstract

The mouse pink-eyed dilution (p) locus on chromosome 7 is associated with defects of skin, eye and coat pigmentation. Mutations at p cause a reduction of eumelanin (black-brown) pigment and altered morphology of black pigment granules (eumelanosomes), but have little effect on pheomelanin (yellow-red) pigment. We show here that the human complementary DNA DN10, linked to the p locus in mice, identifies the human homologue (P) of the mouse p gene, and appears to encode an integral membrane transporter protein. The expression pattern of this gene in various p mutant mice correlates with the pigmentation phenotype; moreover, an abnormally sized messenger RNA is detected in one mutant, p(un), which reverts to the normal size in p(un) revertants. The human P gene corresponds to the D15S12 locus within the chromosome segment 15q11-q13, which is typically deleted in patients with Prader-Willi and Angelman syndrome (see ref. 5 for review). These disorders are phenotypically distinct, depending on the parent of origin of the deleted chromosome, but both syndromes are often associated with hypopigmentation of the skin, hair and eyes (see ref. 8 for review), and deletion of the P gene may be responsible for this hypopigmentation. In addition, we report a mutation in both copies of the human P gene in one case of tyrosinase-positive (type II) oculocutaneous albinism, recently linked to 15q11-q13 (ref. 9).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421497     DOI: 10.1038/361072a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  108 in total

1.  Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigen.

Authors:  C E Touloukian; W W Leitner; P F Robbins; S A Rosenberg; N P Restifo
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

2.  Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.

Authors:  J M Newton; O Cohen-Barak; N Hagiwara; J M Gardner; M T Davisson; R A King; M H Brilliant
Journal:  Am J Hum Genet       Date:  2001-09-26       Impact factor: 11.025

3.  A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population.

Authors:  Zanhua Yi; Nanibaa' Garrison; Orit Cohen-Barak; Tatiana M Karafet; Richard A King; Robert P Erickson; Michael F Hammer; Murray H Brilliant
Journal:  Am J Hum Genet       Date:  2002-12-05       Impact factor: 11.025

4.  Pink-eyed dilution protein controls the processing of tyrosinase.

Authors:  Kun Chen; Prashiela Manga; Seth J Orlow
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

5.  Homozygosity mapping in albinism patients using a novel panel of 13 STR markers inside the nonsyndromic OCA genes: introducing 5 novel mutations.

Authors:  Faravareh Khordadpoor-Deilamani; Mohammad Taghi Akbari; Morteza Karimipoor; Gholam Reza Javadi
Journal:  J Hum Genet       Date:  2016-01-28       Impact factor: 3.172

6.  Oculocutaneous albinism in an isolated Tonga community in Zimbabwe.

Authors:  P M Lund; N Puri; D Durham-Pierre; R A King; M H Brilliant
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

7.  Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene.

Authors:  P Manga; J G Kromberg; N F Box; R A Sturm; T Jenkins; M Ramsay
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

8.  Conserved function of medaka pink-eyed dilution in melanin synthesis and its divergent transcriptional regulation in gonads among vertebrates.

Authors:  Shoji Fukamachi; Shuichi Asakawa; Yuko Wakamatsu; Nobuyoshi Shimizu; Hiroshi Mitani; Akihiro Shima
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

Review 9.  A gene map of congenital malformations.

Authors:  A O Wilkie; J S Amberger; V A McKusick
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

10.  An unbalanced translocation unmasks a recessive mutation in the follicle-stimulating hormone receptor (FSHR) gene and causes FSH resistance.

Authors:  Amla Kuechler; Berthold P Hauffa; Angela Köninger; Gunnar Kleinau; Beate Albrecht; Bernhard Horsthemke; Jörg Gromoll
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.